Work by Xu et al. [35] has highlighted isozyme‐specific regulation, for instance, HK2 downregulation versus PFKL upregulation in prostate cancer, but has not functionally compared the inhibition of these enzymes. This evidence concerns the gene HK2 and prostate carcinoma.